Although BMF has been described as FOXO3 transcriptional target21, and FOXO3 and FOXM1 to function antagonistically in cancer cells35, we found FOXO3 depletion to induce BMF upregulation and FOXM1 downregulation in HDFs (Fig. S6b). The gene discussed is FOXO3; the disease is cancer.